Key Record Dates
ClinicalTrials.gov Identifier: | NCT05756907 |
---|---|
Brief Title: | Combination of SON-1010 (IL12-FHAB) and Atezolizumab in Patients With Platinum-resistant Ovarian Cancer |
First Submitted : | February 23, 2023 |
First Submitted that Met QC Criteria : | February 23, 2023 |
First Posted : | March 7, 2023 |
Last Update Submitted that Met QC Criteria : | October 19, 2023 |
Last Update Posted : | October 23, 2023 |